# CF Bankshares Inc.: Form 10-Q for the period ended Jun 30, 2023

- Company: [CF Bankshares Inc.](/companies/cfbk.md) (CIK 1070680)
- Form: 10-Q
- Filed: 2023-08-11
- Accepted by EDGAR: Aug 11, 2023, 11:23 ET
- Period: 2023-06-30
- Accession: 0001070680-23-000033
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070680/000107068023000033/cfbk-20230630x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070680/000107068023000033/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Interest expense | 3 months, 2023-04-01 to 2023-06-30 | $14.7m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2023-01-01 to 2023-06-30 | $26.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2023-04-01 to 2023-06-30 | $1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2023-01-01 to 2023-06-30 | $2.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2023-04-01 to 2023-06-30 | $4.2m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2023-01-01 to 2023-06-30 | $8.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2023-04-01 to 2023-06-30 | $0.66 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2023-01-01 to 2023-06-30 | $1.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2023-04-01 to 2023-06-30 | $0.66 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2023-01-01 to 2023-06-30 | $1.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2023-04-01 to 2023-06-30 | 6,433,623 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2023-01-01 to 2023-06-30 | 6,431,508 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2023-01-01 to 2023-06-30 | $7.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2023-01-01 to 2023-06-30 | $648.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2023-01-01 to 2023-06-30 | $705.0k | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2023-06-30 | $231.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2023-06-30 | $1.96bn | us-gaap:Assets |
| Total liabilities | at 2023-06-30 | $1.82bn | us-gaap:Liabilities |
| Shareholders' equity | at 2023-06-30 | $147.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,416 characters.

(a) None.

(b) Not applicable.

(c) The following table provides information concerning purchases of the Holding Company’s shares of common stock made by or on behalf of the Company or any “affiliated purchaser” as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended, during the three months ended June 30, 2023.

| Period | Total number of common shares purchased |  | Average price paid per common share | Total number of common shares purchased as part of publicly announced plans or programs (2) | Maximum number of common shares that may yet be purchased under the plans or programs |
| --- | ---: | ---: | ---: | ---: | ---: |
| April 1, 2023 through April 30, 2023 | 502 | (1) | 16.94 | - | - |
| May 1, 2023 through May, 31 2023 | - |  | - | - | - |
| June 1, 2023 through June 30, 2023 | - |  | - | - | - |
| Total | 502 |  | $16.94 | - | - |

(1) Represents shares of common stock surrendered to the Company for the payment of the exercise price and taxes upon the exercise of stock options.

(2) The Company had no publicly announced plans or programs regarding the purchase of the Company’s common stock in effect during the second quarter of 2023. However, on July 5, 2023, the Company’s Board of Directors authorized a new stock repurchase program pursuant to which the Company may repurchase up to 250,000 shares of the Company’s common stock on or before June 30, 2024.

## Risk factors

As filed, 450 characters.

There are certain risks and uncertainties in our business that could cause our actual results to differ materially from those anticipated. A detailed discussion of our risk factors is included in “Item 1A. Risk Factors” of Part I of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as supplemented by “Item IA. Risk Factors” of Part II of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023.

Filed Aug 11, 2023.
Source: SEC EDGAR, the filing index for accession 0001070680-23-000033. Last ingested by Listed: Nov 13, 2026, 01:50 ET. No prices; not investment advice.
